These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33424607)
1. Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer. Siraj AK; Pratheeshkumar P; Divya SP; Parvathareddy SK; Alobaisi KA; Thangavel S; Siraj S; Al-Badawi IA; Al-Dayel F; Al-Kuraya KS Front Pharmacol; 2020; 11():598880. PubMed ID: 33424607 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value and Function of KLF5 in Papillary Thyroid Cancer. Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Siraj S; Diaz R; Begum R; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430300 [TBL] [Abstract][Full Text] [Related]
3. Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity. Wu CJ; Sundararajan V; Sheu BC; Huang RY; Wei LH Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861720 [No Abstract] [Full Text] [Related]
4. microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer. Yang A; Wang X; Yu C; Jin Z; Wei L; Cao J; Wang Q; Zhang M; Zhang L; Zhang L; Hao C Oncol Lett; 2017 Sep; 14(3):3177-3184. PubMed ID: 28927063 [TBL] [Abstract][Full Text] [Related]
5. SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway. Chen M; Zeng J; Chen S; Li J; Wu H; Dong X; Lei Y; Zhi X; Yao L Aging (Albany NY); 2020 Jun; 12(11):10896-10911. PubMed ID: 32516133 [TBL] [Abstract][Full Text] [Related]
6. KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway. Liu FF; Dong L; Yang X; Li DJ; Shen YY; Liu ZL Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3867-3875. PubMed ID: 31115014 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer. Ma Z; Wang X; He J; Xia J; Li Y PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289 [TBL] [Abstract][Full Text] [Related]
8. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells. Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689 [TBL] [Abstract][Full Text] [Related]
9. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer. Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823 [TBL] [Abstract][Full Text] [Related]
11. The transcription factor Krüppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma. An T; Dong T; Zhou H; Chen Y; Zhang J; Zhang Y; Li Z; Yang X Biochem Biophys Res Commun; 2019 Jan; 508(1):159-168. PubMed ID: 30473218 [TBL] [Abstract][Full Text] [Related]
12. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells. Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells. Wang B; Liu M; Zhuang R; Jiang J; Gao J; Wang H; Chen H; Zhang Z; Kuang Y; Li P Oncol Lett; 2018 Mar; 15(3):3369-3375. PubMed ID: 29435081 [TBL] [Abstract][Full Text] [Related]
14. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
15. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer. Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer. Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
18. Dual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer. Hussain AR; Al-Romaizan M; Ahmed M; Thangavel S; Al-Dayel F; Beg S; Uddin S; Siraj AK; Al-Kuraya KS Mol Med; 2015 May; 21(1):466-78. PubMed ID: 26023849 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer. Cao Y; Shi H; Ren F; Jia Y; Zhang R Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]